Trump Announces Wegovy, Zepbound Price Cuts in Deal With Lilly and Novo Nordisk
Trump weight-loss drug deal: what was announced On Nov. 6, 2025, President Donald Trump announced agreements with Eli Lilly and Novo Nordisk to substantially lower retail and government prices for popular GLP-1 weight-loss drugs — notably Zepbound (Lilly) and Wegovy (Novo Nordisk). The plan pairs reduced list prices through a White House initiative called TrumpRx…